These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR; Yeshurun D; Jackson RL; Gotto AM Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
23. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias. Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723 [No Abstract] [Full Text] [Related]
24. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia]. Warembourg H; Jaillard J Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605 [No Abstract] [Full Text] [Related]
25. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens. Watermeyer GS; Mann JI; Truswell AS; Levy I S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562 [TBL] [Abstract][Full Text] [Related]
26. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy. Zelis R; Amsterdam EA; Spann JF; Mason DT JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727 [No Abstract] [Full Text] [Related]
27. Secholex, Clofibrate and taurine in hyperlipidaemia. Howard AN; Evans RJ Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405 [No Abstract] [Full Text] [Related]
28. [Overviews of fibrate]. Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141 [No Abstract] [Full Text] [Related]
29. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P; Schwandt P Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of hyperlipoidaemias]. Wolfram G Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214 [No Abstract] [Full Text] [Related]
31. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid]. Hanefeld M; Schulze J; Fritz T; Kemmer C Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340 [No Abstract] [Full Text] [Related]
32. [Atherosclerosis. Its implications, prevention and dietetic and pharmacological treatment]. Sangiorgi M; Martinelli M Minerva Med; 1978 Dec; 69(61):4227-33. PubMed ID: 733078 [No Abstract] [Full Text] [Related]
33. Gemfibrozil treatment: a comparison with clofibrate. Howard AN; Ghosh P Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609 [TBL] [Abstract][Full Text] [Related]
34. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate. Nordoy A; Rodset JM Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488 [No Abstract] [Full Text] [Related]
35. Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate. Samuel P; Holtzman CM; Meilman E; Sekowski I Circulation; 1970 Jan; 41(1):109-14. PubMed ID: 5420622 [No Abstract] [Full Text] [Related]
36. The effect of clofibrate on the serum triglyceride concentration in normal males fed high-sucrose diets. Zakim D; Herman RH J Atheroscler Res; 1969; 10(1):91-5. PubMed ID: 5380907 [No Abstract] [Full Text] [Related]
37. [Clinical and therapeutic evaluation of a new antilipemic substance]. de Aguiar Magano L Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646 [TBL] [Abstract][Full Text] [Related]
38. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. Best MM; Duncan CH Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616 [No Abstract] [Full Text] [Related]
39. Serum cholesterol and triglycerides. Myant NB Practitioner; 1973 Aug; 211(262):188-92. PubMed ID: 4728419 [No Abstract] [Full Text] [Related]